Across the healthcare continuum, there is a shared common concern regarding rising drug spend and drug pricing. EQRx’s innovative business model addresses the profound need for a more collaborative approach across the ecosystem to solve the challenges of patient access to innovative medicine at radically lower prices.

Bio

Kent Rogers is an accomplished senior executive with more than 28 years of experience in product commercialization, sales and marketing, and supply chain logistics, as well as pricing, reimbursement, market access, and growth strategies across the biotech and pharmaceutical industry. Most recently, he was senior vice president of industry relations at OptumRx, a United Health Group company, leading the formulary contracting and specialty procurement function. Kent previously held leadership roles at the Blue Fin Group, Acorda Therapeutics, Schering-Plough, and Merck.

Kent holds a Bachelor of Science in Business Management from Indiana University and an MBA from Emory University’s Goizueta School of Business.